New hope for diabetics with kidney transplants: islet cells may end insulin shots
NCT ID NCT01123187
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether transplanting insulin-making islet cells could help people with type 1 diabetes who already had a kidney transplant. Fourteen participants received up to three infusions of donor islet cells along with steroid-free immunosuppression. The goal was to see if they could stop taking insulin and keep their blood sugar under control one year later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
islet cell transplant
What this could lead to
If successful, this approach could help some people with type 1 diabetes who have had a kidney transplant achieve insulin independence and better blood sugar control.
What could go wrong
This is a small, early-phase study with only 14 participants, so results may not apply to everyone. The procedure and required immunosuppression carry risks like infection and bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Lille
Lille, Nord, 59000, France